Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (5): 493-498.DOI: 10.3969/j.issn.1673-8640.2025.05.014
Previous Articles Next Articles
XU Dandan
Received:
2024-03-20
Revised:
2024-09-02
Online:
2025-05-30
Published:
2025-06-04
CLC Number:
XU Dandan. Role of lactic acid/albumin ratio in short-term and long-term prognosis evaluation of ventilation therapy in AECOPD patients[J]. Laboratory Medicine, 2025, 40(5): 493-498.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.05.014
指标 | AUC(95%CI①) | P值 | 最佳临界值 | 敏感性/% | 特异性/% | 约登指数 |
---|---|---|---|---|---|---|
APACHEⅡ评分 | 0.824(0.760~0.888) | <0.001 | 22.50分 | 66.7 | 84.6 | 0.513 |
Lac | 0.732(0.666~0.798) | <0.001 | 3.28 mmol·L-1 | 96.7 | 40.0 | 0.367 |
Alb | 0.742(0.674~0.810) | <0.001 | 29.80 g·L-1 | 93.3 | 44.0 | 0.373 |
Lac/Alb比值 | 0.827(0.773~0.881) | <0.001 | 0.14 | 91.7 | 59.4 | 0.511 |
联合检测 | 0.910(0.870~0.950) | <0.001 | 0.249 | 85.0 | 81.7 | 0.667 |
指标 | AUC(95%CI①) | P值 | 最佳临界值 | 敏感性/% | 特异性/% | 约登指数 |
---|---|---|---|---|---|---|
APACHEⅡ评分 | 0.824(0.760~0.888) | <0.001 | 22.50分 | 66.7 | 84.6 | 0.513 |
Lac | 0.732(0.666~0.798) | <0.001 | 3.28 mmol·L-1 | 96.7 | 40.0 | 0.367 |
Alb | 0.742(0.674~0.810) | <0.001 | 29.80 g·L-1 | 93.3 | 44.0 | 0.373 |
Lac/Alb比值 | 0.827(0.773~0.881) | <0.001 | 0.14 | 91.7 | 59.4 | 0.511 |
联合检测 | 0.910(0.870~0.950) | <0.001 | 0.249 | 85.0 | 81.7 | 0.667 |
因素 | β值 | 标准误 | Wald值 | P值 | OR①值(95%CI) |
---|---|---|---|---|---|
年龄 | 1.525 | 0.488 | 9.745 | 0.002 | 4.593(1.764~11.962) |
机械通气 | 0.361 | 0.433 | 0.696 | 0.404 | 1.435(0.615~3.350) |
APACHEⅡ评分 | 2.756 | 0.491 | 31.551 | <0.001 | 15.741(6.016~41.181) |
Lac | 2.923 | 0.932 | 9.826 | 0.002 | 18.591(2.990~115.597) |
Alb | 2.331 | 0.692 | 11.360 | 0.001 | 10.285(2.652~39.885) |
Lac/Alb比值 | 1.521 | 0.661 | 5.288 | 0.021 | 4.577(1.252~16.732) |
因素 | β值 | 标准误 | Wald值 | P值 | OR①值(95%CI) |
---|---|---|---|---|---|
年龄 | 1.525 | 0.488 | 9.745 | 0.002 | 4.593(1.764~11.962) |
机械通气 | 0.361 | 0.433 | 0.696 | 0.404 | 1.435(0.615~3.350) |
APACHEⅡ评分 | 2.756 | 0.491 | 31.551 | <0.001 | 15.741(6.016~41.181) |
Lac | 2.923 | 0.932 | 9.826 | 0.002 | 18.591(2.990~115.597) |
Alb | 2.331 | 0.692 | 11.360 | 0.001 | 10.285(2.652~39.885) |
Lac/Alb比值 | 1.521 | 0.661 | 5.288 | 0.021 | 4.577(1.252~16.732) |
指标 | AUC(95%CI) | P值 | 最佳临界值 | 敏感性/% | 特异性/% | 约登指数 |
---|---|---|---|---|---|---|
APACHEⅡ评分 | 0.835(0.775~0.896) | <0.001 | 21.50分 | 82.4 | 73.7 | 0.561 |
Lac | 0.745(0.678~0.812) | <0.001 | 4.02 mmol·L-1 | 70.6 | 68.9 | 0.395 |
Alb | 0.776(0.714~0.838) | <0.001 | 24.66 g·L-1 | 66.2 | 78.4 | 0.446 |
Lac/Alb比值 | 0.844(0.789~0.900) | <0.001 | 0.16 | 79.4 | 79.0 | 0.584 |
联合检测 | 0.926(0.889~0.964) | <0.001 | 0.268 | 86.8 | 86.2 | 0.730 |
指标 | AUC(95%CI) | P值 | 最佳临界值 | 敏感性/% | 特异性/% | 约登指数 |
---|---|---|---|---|---|---|
APACHEⅡ评分 | 0.835(0.775~0.896) | <0.001 | 21.50分 | 82.4 | 73.7 | 0.561 |
Lac | 0.745(0.678~0.812) | <0.001 | 4.02 mmol·L-1 | 70.6 | 68.9 | 0.395 |
Alb | 0.776(0.714~0.838) | <0.001 | 24.66 g·L-1 | 66.2 | 78.4 | 0.446 |
Lac/Alb比值 | 0.844(0.789~0.900) | <0.001 | 0.16 | 79.4 | 79.0 | 0.584 |
联合检测 | 0.926(0.889~0.964) | <0.001 | 0.268 | 86.8 | 86.2 | 0.730 |
因素 | β值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
年龄 | 0.136 | 0.459 | 0.088 | 0.766 | 1.146(0.466~2.819) |
合并冠心病 APACHEⅡ评分 | 3.072 | 0.505 | 37.048 | <0.001 | 21.595(8.029~58.079) |
1.266 | 0.550 | 5.305 | 0.021 | 3.548(1.208~10.425) | |
Lac | 0.602 | 0.582 | 1.069 | 0.301 | 1.826(0.583~5.714) |
Alb | 1.344 | 0.488 | 7.573 | 0.006 | 3.833(1.472~9.980) |
Lac/Alb比值 | 2.096 | 0.626 | 11.200 | <0.001 | 8.134(2.383~27.761) |
因素 | β值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
年龄 | 0.136 | 0.459 | 0.088 | 0.766 | 1.146(0.466~2.819) |
合并冠心病 APACHEⅡ评分 | 3.072 | 0.505 | 37.048 | <0.001 | 21.595(8.029~58.079) |
1.266 | 0.550 | 5.305 | 0.021 | 3.548(1.208~10.425) | |
Lac | 0.602 | 0.582 | 1.069 | 0.301 | 1.826(0.583~5.714) |
Alb | 1.344 | 0.488 | 7.573 | 0.006 | 3.833(1.472~9.980) |
Lac/Alb比值 | 2.096 | 0.626 | 11.200 | <0.001 | 8.134(2.383~27.761) |
[1] | MATHIOUDAKIS A G, JANSSENS W, SIVAPALAN P, et al. Acute exacerbations of chronic obstructive pulmonary disease:in search of diagnostic biomarkers and treatable traits[J]. Thorax, 2020, 75(6):520-527. |
[2] | 邓波, 吴仕平, 杨兴, 等. 无创呼吸机联合高流量氧疗治疗慢阻肺急性加重期合并呼吸衰竭患者疗效及对血清乳酸hs-CRP水平和血气指标的影响[J]. 河北医学, 2022, 28(11):1845-1850. |
[3] | 胡海涛, 李自健, 胡振红, 等. BiPAP正压无创呼吸机辅助治疗老年AECOPD的临床疗效及对患者肺功能,血清炎性因子和预后指标的影响[J]. 现代生物医学进展, 2021, 21(12):2275-2279. |
[4] | 李明, 王德勇, 袁娟, 等. 血清TLR4,PA,Lac水平与老年患者全身麻醉手术后肺部感染程度及预后的关系[J]. 山东医药, 2021, 61(23):61-63. |
[5] | 荆堂堂, 沈冬明, 严春霞. 慢性肾脏病血液透析期间合并感染患者血清PCT,HCT,Alb水平变化及其临床意义[J]. 海南医学, 2023, 34(6):845-848. |
[6] | 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J]. 国际呼吸杂志, 2014, 34(1):1-11. |
[7] | ZIMMERMAN J E, KRAMER A A, MCNAIR D S, et al. Acute Physiology and Chronic Health Evaluation(APACHE)Ⅳ:hospital mortality assessment for today's critically ill patients[J]. Crit Care Med, 2006, 34(5):1297-1310. |
[8] | 吴颖, 姚娜. 不同压力无创正压通气对慢性阻塞性肺疾病急性加重期伴Ⅱ型呼吸衰竭患者的临床疗效及预后研究[J]. 贵州医药, 2022, 46(8):1198-1199. |
[9] | LEE S, CHOI Y, JEONG E, et al. Physiological significance of elevated levels of lactate by exercise training in the brain and body[J]. J Biosci Bioeng, 2023, 135(3):167-175. |
[10] | ZINELLU E, FOIS A G, SOTGIU E, et al. Serum albumin concentrations in stable chronic obstructive pulmonary disease:a systematic review and meta-analysis[J]. J Clin Med, 2021, 10(2):269. |
[11] | 封慧, 李琴, 李思睿. 脓毒症休克患者动脉血乳酸,血清白蛋白比值在预测病情评估及转归的临床价值[J]. 中国实验诊断学, 2023, 27(1):37-40. |
[12] | 赵善隽, 陈君, 王大宇. 血红蛋白和血清白蛋白评估老年慢性心力衰竭长期预后的价值[J]. 心脏杂志, 2022, 34(3):299-303. |
[13] | 姚运海, 赵卫峰, 甘建和. 终末期肝病模型联合动脉血乳酸对乙型肝炎病毒相关慢加急性肝衰竭预后的评价:97例患者的回顾性分析[J]. 中华肝脏病杂志, 2019, 27(4):256-260. |
[14] | GOMEZ J C, DOERSCHUK C M. Hypoxia can make neutrophils hyper,potentially wreaking havoc during exacerbations in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2022, 205(8):862-864. |
[15] | FEKETE M, PÁKÓ J, SZŐLLŐSI G, et al. Significance of nutritional status in chronic obstructive pulmonary disease:a survey[J]. Orv Hetil, 2020, 161(40):1711-1719. |
[16] |
CHEN L, CHEN L, ZHENG H, et al. Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure[J]. BMC Pulm Med, 2021, 21(1):258.
DOI PMID |
[17] | 黄振, 刘乃嘉. 血乳酸联合APACHEⅡ评分预测慢性阻塞性肺疾病急性加重期并呼吸衰竭预后的价值[J]. 局解手术学杂志, 2023, 32(9):795-799. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||